Cartiva’s Challenge: Moving the Market with a First-in-Class Motion-Preserving Toe Implant

article image

Cartiva’s synthetic cartilage implant for osteoarthritis of the great toe is the first PMA-approved device for the forefoot, illustrating both the complexities and advantages of undertaking a lengthy and costly path to market that, having long been considered a niche, is fast gaining mainstream attention.

Osteoarthritis of the great toe, or hallux rigidus, is the most common arthritis in the foot, affecting almost three million people.


This article is restricted to subscribers only.

Sign in to continue reading.


We're here to help! Please contact us at: